These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15546216

  • 1. Radiopharmaceuticals for assessment of multidrug resistance P-glycoprotein-mediated drug transport activity.
    Sharma V.
    Bioconjug Chem; 2004; 15(6):1464-74. PubMed ID: 15546216
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.
    Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V.
    Dalton Trans; 2010 Jul 07; 39(25):5842-50. PubMed ID: 20505882
    [Abstract] [Full Text] [Related]

  • 3. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases.
    Sivapackiam J, Gammon ST, Harpstrite SE, Sharma V.
    Methods Mol Biol; 2010 Jul 07; 596():141-81. PubMed ID: 19949924
    [Abstract] [Full Text] [Related]

  • 4. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM.
    Cancer Res; 1993 Mar 01; 53(5):977-84. PubMed ID: 8094997
    [Abstract] [Full Text] [Related]

  • 5. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
    Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D.
    J Nucl Med; 1998 Jan 01; 39(1):77-86. PubMed ID: 9443741
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R.
    Cancer Chemother Pharmacol; 2005 Aug 01; 56(2):173-81. PubMed ID: 15824923
    [Abstract] [Full Text] [Related]

  • 7. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
    Shen X, Chen G, Zhu G, Fong WF.
    Bioorg Med Chem; 2006 Nov 01; 14(21):7138-45. PubMed ID: 16875827
    [Abstract] [Full Text] [Related]

  • 8. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R.
    Planta Med; 2006 Jun 01; 72(7):634-9. PubMed ID: 16739070
    [Abstract] [Full Text] [Related]

  • 9. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
    Pichler A, Zelcer N, Prior JL, Kuil AJ, Piwnica-Worms D.
    Clin Cancer Res; 2005 Jun 15; 11(12):4487-94. PubMed ID: 15958634
    [Abstract] [Full Text] [Related]

  • 10. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF, Wan CK, Zhu GY, Chattopadhyay A, Dey S, Zhao Z, Shen XL.
    Planta Med; 2007 Mar 15; 73(3):212-20. PubMed ID: 17318783
    [Abstract] [Full Text] [Related]

  • 11. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo.
    Sharma V, Beatty A, Wey SP, Dahlheimer J, Pica CM, Crankshaw CL, Bass L, Green MA, Welch MJ, Piwnica-Worms D.
    Chem Biol; 2000 May 15; 7(5):335-43. PubMed ID: 10801474
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V, Prior JL, Belinsky MG, Kruh GD, Piwnica-Worms D.
    J Nucl Med; 2005 Feb 15; 46(2):354-64. PubMed ID: 15695797
    [Abstract] [Full Text] [Related]

  • 13. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD, Sharom FJ.
    Biochemistry; 2008 Dec 23; 47(51):13686-98. PubMed ID: 19049391
    [Abstract] [Full Text] [Related]

  • 14. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R, Katzir H, Yeheskely-Hayon D, Eytan GD.
    FEBS J; 2007 Dec 23; 274(23):6204-14. PubMed ID: 17986257
    [Abstract] [Full Text] [Related]

  • 15. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.
    Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
    Bergmann R, Brust P, Scheunemann M, Pietzsch HJ, Seifert S, Roux F, Johannsen B.
    Nucl Med Biol; 2000 Feb 28; 27(2):135-41. PubMed ID: 10773542
    [Abstract] [Full Text] [Related]

  • 17. Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals.
    Piwnica-Worms D, Sharma V.
    Curr Top Med Chem; 2010 Feb 28; 10(17):1834-45. PubMed ID: 20645914
    [Abstract] [Full Text] [Related]

  • 18. Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1.
    Findling-Kagan S, Sivan H, Ostrovsky O, Nagler A, Galski H.
    Leuk Res; 2005 Apr 28; 29(4):407-14. PubMed ID: 15725475
    [Abstract] [Full Text] [Related]

  • 19. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Cancer Invest; 2008 May 28; 26(4):344-51. PubMed ID: 18443954
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X, Sui M, Fan W.
    Anticancer Res; 2005 May 28; 25(3B):1953-62. PubMed ID: 16158930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.